Last 12 months
Inside the activity.
5 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 1 | 0 |
| Jul 2026 | 4 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 19, 2022 Filed Sep 20, 2022 23:11 UTC |
Claiborne Cary JDirector · Chief Executive Officer
|
GrantCommon Stock | 25,000 | $0.43 | $10,735.00 |
DisclosureSEC source: 0001213900-22-057513 · ownership.xml · nonDerivative · entry 1 Claiborne Cary J · CIK 0001370930 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,025,000 F1 · price: The price reported is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $0.4196 through $0.4573, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| August 22, 2022 Filed Aug 23, 2022 19:14 UTC |
Stilley William B. IIIDirector
|
GrantStock Options · Derivative | 100,000 | $0.00 Strike: $0.56 | $0.00 |
DisclosureSEC source: 0001213900-22-050596 · ownership.xml · derivative · entry 1 Stilley William B. III · CIK 0001718069 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2032-08-21 F1 · derivative.exercise_date: Stock options to purchase 100,000 shares of the Company's common stock, vesting 50% after Purnovate, Inc. has held a pre-IND meeting with the FDA and the balance when the IND is granted. Read SEC document |
| August 18, 2022 Filed Aug 22, 2022 20:42 UTC |
Claiborne Cary JChief Executive Officer
|
GrantCommon Stock | 1,000,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-22-050082 · ownership.xml · nonDerivative · entry 1 Claiborne Cary J · CIK 0001370930 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000,000 F1 · shares: These are Restricted Stock Units that vest monthly pro rata over the next 36 months. Read SEC document |
| June 27, 2022 Filed Jun 28, 2022 22:02 UTC |
Goodman TonyDirector
|
GrantStock Option · Derivative | 25,000 | $0.00 Strike: $1.23 | $0.00 |
DisclosureSEC source: 0001213900-22-035649 · ownership.xml · derivative · entry 1 Goodman Tony · CIK 0001717971 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2032-06-26 F1 · shares: The option vests pro rata on a monthly basis over 36 months. F1 · derivative.exercise_date: The option vests pro rata on a monthly basis over 36 months. Read SEC document |
| February 23, 2022 Filed Feb 25, 2022 20:05 UTC |
Goodman TonyDirector
|
GrantStock Option · Derivative | 40,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001213900-22-009440 · ownership.xml · derivative · entry 1 Goodman Tony · CIK 0001717971 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2032-02-22 F1 · shares: The option vests pro rata on a monthly basis over 36 months commencing March 23, 2022. F1 · derivative.exercise_date: The option vests pro rata on a monthly basis over 36 months commencing March 23, 2022. Read SEC document |
| February 23, 2022 Filed Feb 25, 2022 15:00 UTC |
Stilley William B. IIIDirector · Chief Executive Officer
|
GrantCommon Stock | 250,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-22-009432 · ownership.xml · nonDerivative · entry 1 Stilley William B. III · CIK 0001718069 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,187,646 F1 · shares: The restricted shares of Adial Pharmaceuticals, Inc. (the "Company") common stock, par value $0.001 per share (the "Common Stock"), vest as to 166,667 shares monthly on a pro rata basis over 24 months commencing March 23, 2022 and vest as to 83,333 shares on the three year anniversary of the grant date. F1 · balance_after: The restricted shares of Adial Pharmaceuticals, Inc. (the "Company") common stock, par value $0.001 per share (the "Common Stock"), vest as to 166,667 shares monthly on a pro rata basis over 24 months commencing March 23, 2022 and vest as to 83,333 shares on the three year anniversary of the grant date. Read SEC document |
| February 23, 2022 Filed Feb 25, 2022 15:02 UTC |
Truluck JosephChief Financial Officer
|
GrantEmployee Stock Option · Derivative | 100,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001213900-22-009437 · ownership.xml · derivative · entry 1 Truluck Joseph · CIK 0001718091 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2032-02-22 F1 · shares: The option vests pro rata on a monthly basis over 36 months commencing March 23, 2022. F1 · derivative.exercise_date: The option vests pro rata on a monthly basis over 36 months commencing March 23, 2022. Read SEC document |
| February 23, 2022 Filed Feb 25, 2022 15:18 UTC |
Johnson Bankole A.Chief Medical Officer
|
GrantEmployee Stock Option · Derivative | 35,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001213900-22-009451 · ownership.xml · derivative · entry 1 Johnson Bankole A. · CIK 0001718158 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2032-02-22 F1 · shares: The option vests pro rata on a monthly basis over 36 months commencing March 23, 2022. F1 · derivative.exercise_date: The option vests pro rata on a monthly basis over 36 months commencing March 23, 2022. Read SEC document |
| February 23, 2022 Filed Feb 25, 2022 19:54 UTC |
Claiborne Cary JChief Operating Officer
|
GrantEmployee Stock Option · Derivative | 6,667 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001213900-22-009419 · ownership.xml · derivative · entry 1 Claiborne Cary J · CIK 0001370930 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,667 Underlying: Common Stock · 6,667 shares Expires 2032-02-22 F1 · shares: The option vests pro rata on a monthly basis over 36 months commencing March 23, 2022. F1 · derivative.exercise_date: The option vests pro rata on a monthly basis over 36 months commencing March 23, 2022. Read SEC document |
| February 23, 2022 Filed Feb 25, 2022 19:59 UTC |
Schuyler KevinDirector
|
GrantStock Option · Derivative | 40,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001213900-22-009430 · ownership.xml · derivative · entry 1 Schuyler Kevin · CIK 0001718094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2032-02-22 F1 · shares: The option vests pro rata on a monthly basis over 36 months commencing March 23, 2022. F1 · derivative.exercise_date: The option vests pro rata on a monthly basis over 36 months commencing March 23, 2022. Read SEC document |
| February 23, 2022 Filed Feb 25, 2022 19:57 UTC |
Newman James W. Jr.Director
|
GrantStock Option · Derivative | 40,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001213900-22-009425 · ownership.xml · derivative · entry 1 Newman James W. Jr. · CIK 0001718364 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2032-02-22 F1 · shares: The option vests pro rata on a monthly basis over 36 months commencing March 23, 2022. F1 · derivative.exercise_date: The option vests pro rata on a monthly basis over 36 months commencing March 23, 2022. Read SEC document |
| February 23, 2022 Filed Feb 25, 2022 19:53 UTC |
Anderson J. KermitDirector
|
GrantStock Option · Derivative | 40,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001213900-22-009417 · ownership.xml · derivative · entry 1 Anderson J. Kermit · CIK 0001717983 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2032-02-22 F1 · shares: The option vests pro rata on a monthly basis over 36 months commencing March 23, 2022. F1 · derivative.exercise_date: The option vests pro rata on a monthly basis over 36 months commencing March 23, 2022. Read SEC document |
| February 23, 2022 Filed Feb 25, 2022 19:55 UTC |
Gilliland Robertson H.Director
|
GrantStock Option · Derivative | 40,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001213900-22-009422 · ownership.xml · derivative · entry 1 Gilliland Robertson H. · CIK 0001718351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2032-02-22 F1 · shares: The option vests pro rata on a monthly basis over 36 months commencing March 23, 2022. F1 · derivative.exercise_date: The option vests pro rata on a monthly basis over 36 months commencing March 23, 2022. Read SEC document |
| December 30, 2021 Filed Jan 3, 2022 15:39 UTC |
Newman James W. Jr.Director
|
PurchaseCommon Stock | 10,000 | $2.71 | $27,100.00 |
DisclosureSEC source: 0001213900-22-000067 · ownership.xml · nonDerivative · entry 6 Newman James W. Jr. · CIK 0001718364 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Roth IRA FBO James W Newman, Jr. Disclosed balance after: 34,644 F6 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transaction at prices ranging from $2.655 to $2.72, inclusive. F8 · ownership.nature: Courtney Newman is the daughter of James W. Newman, Jr. Read SEC document |
| December 30, 2021 Filed Jan 3, 2022 15:39 UTC |
Newman James W. Jr.Director
|
PurchaseCommon Stock | 5,000 | $2.72 | $13,600.00 |
DisclosureSEC source: 0001213900-22-000067 · ownership.xml · nonDerivative · entry 5 Newman James W. Jr. · CIK 0001718364 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Ivy Cottage Group, LLC Disclosed balance after: 50,221 F5 · ownership.nature: James W. Newman is the general partner of Ivy Cottage Group, LLC. Read SEC document |
| December 30, 2021 Filed Jan 3, 2022 15:39 UTC |
Newman James W. Jr.Director
|
PurchaseCommon Stock | 10,000 | $2.66 | $26,600.00 |
DisclosureSEC source: 0001213900-22-000067 · ownership.xml · nonDerivative · entry 1 Newman James W. Jr. · CIK 0001718364 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 F1 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transaction at prices ranging from $2.628 to $2.68, inclusive. The reporting person undertakes to provide Adial Pharmaceuticals, Inc., any security holder of Adial Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (6) of this Form 4. Read SEC document |
| December 23, 2021 Filed Dec 23, 2021 22:04 UTC |
Schuyler KevinDirector · 10% owner
|
GiftWarrant to purchase common stock · Derivative | 90,000 | $0.00 Strike: $6.25 | $0.00 |
DisclosureSEC source: 0001213900-21-067352 · ownership.xml · derivative · entry 4 Schuyler Kevin · CIK 0001718094 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 90,000 shares Expires 2023-07-31 F1 · kind: Mr. Schuyler gifted the securities to a newly formed charitable trust (the "Trust"), the trustee of which is his adult son who controls the Trust. Read SEC document |
| December 23, 2021 Filed Dec 23, 2021 22:04 UTC |
Schuyler KevinDirector · 10% owner
|
GiftCommon Stock | 312,990 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-21-067352 · ownership.xml · nonDerivative · entry 1 Schuyler Kevin · CIK 0001718094 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Mr. Schuyler gifted the securities to a newly formed charitable trust (the "Trust"), the trustee of which is his adult son who controls the Trust. Read SEC document |
| December 07, 2021 Filed Dec 9, 2021 02:23 UTC |
Claiborne Cary JDirector · Chief Operating Officer
|
GrantStock options · Derivative | 130,000 | $0.00 Strike: $2.77 | $0.00 |
DisclosureSEC source: 0001213900-21-064281 · ownership.xml · derivative · entry 1 Claiborne Cary J · CIK 0001370930 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,000 Underlying: Common stock · 130,000 shares Expires 2031-12-08 F1 · derivative.exercise_date: The option vests pro rata on a monthly basis over 36 months. Read SEC document |
| November 30, 2021 Filed Dec 1, 2021 09:25 UTC |
Stilley William B. IIIDirector · Chief Executive Officer · 10% owner
|
PurchaseCommon Stock | 10,600 | $2.75 | $29,178.62 |
DisclosureSEC source: 0001213900-21-062729 · ownership.xml · nonDerivative · entry 2 Stilley William B. III · CIK 0001718069 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 937,646 F2 · shares: The price reported in Column 4 is a weighted average price. These 10,600 shares of common stock were purchased in multiple transactions at prices ranging from $2.5999 to $2.83, inclusive. The reporting person undertakes to provide to Adial Pharmaceuticals, Inc., any security holder of Adial Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4 F2 · price: The price reported in Column 4 is a weighted average price. These 10,600 shares of common stock were purchased in multiple transactions at prices ranging from $2.5999 to $2.83, inclusive. The reporting person undertakes to provide to Adial Pharmaceuticals, Inc., any security holder of Adial Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4 Read SEC document |
| November 29, 2021 Filed Dec 1, 2021 09:25 UTC |
Stilley William B. IIIDirector · Chief Executive Officer · 10% owner
|
PurchaseCommon Stock | 10,000 | $2.59 | $25,892.00 |
DisclosureSEC source: 0001213900-21-062729 · ownership.xml · nonDerivative · entry 1 Stilley William B. III · CIK 0001718069 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 927,046 F1 · shares: The price reported in Column 4 is a weighted average price. These 10,000 shares of common stock were purchased in multiple transactions at prices ranging from $2.54 to $2.60, inclusive. The reporting person undertakes to provide to Adial Pharmaceuticals, Inc., any security holder of Adial Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4 F1 · price: The price reported in Column 4 is a weighted average price. These 10,000 shares of common stock were purchased in multiple transactions at prices ranging from $2.54 to $2.60, inclusive. The reporting person undertakes to provide to Adial Pharmaceuticals, Inc., any security holder of Adial Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4 Read SEC document |
| November 26, 2021 Filed Nov 30, 2021 14:25 UTC |
Newman James W. Jr.Director
|
PurchaseCommon Stock | 10,000 | $2.85 | $28,500.00 |
DisclosureSEC source: 0001213900-21-062465 · ownership.xml · nonDerivative · entry 1 Newman James W. Jr. · CIK 0001718364 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Rountop Limited Partnership, LLP Disclosed balance after: 34,475 F1 · ownership.nature: James W. Newman, Jr. is the general partner of Roundtop Limited Partnership, LLP. Read SEC document |
| November 02, 2021 Filed Nov 3, 2021 20:35 UTC |
Claiborne Cary JDirector
|
GrantStock Option · Derivative | 60,000 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001213900-21-056466 · ownership.xml · derivative · entry 1 Claiborne Cary J · CIK 0001370930 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2031-11-01 F1 · shares: The option vests pro rata on a monthly basis over 36 months. F1 · derivative.exercise_date: The option vests pro rata on a monthly basis over 36 months. Read SEC document |
| October 04, 2021 Filed Oct 6, 2021 17:22 UTC |
Johnson Bankole A.Chief Medical Officer
|
OtherWarrant · Derivative | 150,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-21-051646 · ownership.xml · derivative · entry 2 Johnson Bankole A. · CIK 0001718158 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,714 Underlying: Common Stock · 150,000 shares Expires not disclosed F3 · derivative.exercise_price: On October 4, 2021, Dr. Johnson sold warrants to purchase 150,000 shares of the issuer's common stock pursuant to the SPA, for an aggregate purchase price of $1,500. The warrants provide for an exercise price of $6.25 per share and expire five years after issuance. F3 · kind: On October 4, 2021, Dr. Johnson sold warrants to purchase 150,000 shares of the issuer's common stock pursuant to the SPA, for an aggregate purchase price of $1,500. The warrants provide for an exercise price of $6.25 per share and expire five years after issuance. F3 · price: On October 4, 2021, Dr. Johnson sold warrants to purchase 150,000 shares of the issuer's common stock pursuant to the SPA, for an aggregate purchase price of $1,500. The warrants provide for an exercise price of $6.25 per share and expire five years after issuance. F3 · derivative.exercise_date: On October 4, 2021, Dr. Johnson sold warrants to purchase 150,000 shares of the issuer's common stock pursuant to the SPA, for an aggregate purchase price of $1,500. The warrants provide for an exercise price of $6.25 per share and expire five years after issuance. F3 · derivative.expiration_date: On October 4, 2021, Dr. Johnson sold warrants to purchase 150,000 shares of the issuer's common stock pursuant to the SPA, for an aggregate purchase price of $1,500. The warrants provide for an exercise price of $6.25 per share and expire five years after issuance. Read SEC document |
| October 04, 2021 Filed Oct 6, 2021 17:22 UTC |
Johnson Bankole A.Chief Medical Officer
|
SaleCommon Stock | 200,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-21-051646 · ownership.xml · nonDerivative · entry 1 Johnson Bankole A. · CIK 0001718158 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By En Fideicomiso De Mi Vida 11/23/2010 (Trust) Disclosed balance after: 148,246 F1 · kind: En Fideicomiso De Mi Vida 11/23/2010 (the "Trust") sold 200,000 shares of the issuer's common stock pursuant to a Stock Purchase Agreement dated as of October 1, 2021 (the "SPA"), for an aggregate purchase price of $200,000. F1 · price: En Fideicomiso De Mi Vida 11/23/2010 (the "Trust") sold 200,000 shares of the issuer's common stock pursuant to a Stock Purchase Agreement dated as of October 1, 2021 (the "SPA"), for an aggregate purchase price of $200,000. F2 · ownership.nature: Dr. Johnson is the trustee of the Trust. Read SEC document |
| April 06, 2021 Filed Apr 8, 2021 21:47 UTC |
Johnson Bankole A.Chief Medical Officer
|
SaleCommon Stock | 150,000 | $2.50 | $375,000.00 |
DisclosureSEC source: 0001213900-21-020918 · ownership.xml · nonDerivative · entry 3 Johnson Bankole A. · CIK 0001718158 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Indirect · En Fideicomiso De Mi Vida 11/23/2010 (Trust) Disclosed balance after: 548,336 F1 · kind: The reporting person sold 150,000 shares of the issuer's common stock pursuant to a Stock Purchase Agreement dated as of April 6, 2021 for an aggregate purchase price of $375,000. F3 · ownership.nature: Dr. Johnson is the trustee of each of these trusts. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 22:51 UTC |
Goodman TonyDirector
|
GrantStock Option · Derivative | 40,000 | $0.00 Strike: $3.11 | $0.00 |
DisclosureSEC source: 0001213900-21-008162 · ownership.xml · derivative · entry 1 Goodman Tony · CIK 0001717971 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2031-02-07 F1 · shares: The option vests pro rata on a monthly basis over 36 months. F1 · derivative.exercise_date: The option vests pro rata on a monthly basis over 36 months. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 18:10 UTC |
Stilley William B. IIIDirector · Chief Executive Officer
|
GrantEmployee Stock Option · Derivative | 250,000 | $0.00 Strike: $3.11 | $0.00 |
DisclosureSEC source: 0001213900-21-008172 · ownership.xml · derivative · entry 1 Stilley William B. III · CIK 0001718069 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2031-02-07 F1 · shares: The option vests pro rata on a monthly basis over 36 months. F1 · derivative.exercise_date: The option vests pro rata on a monthly basis over 36 months. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 18:12 UTC |
Truluck JosephChief Financial Officer
|
GrantEmployee Stock Option · Derivative | 125,000 | $0.00 Strike: $3.11 | $0.00 |
DisclosureSEC source: 0001213900-21-008175 · ownership.xml · derivative · entry 1 Truluck Joseph · CIK 0001718091 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2031-02-07 F1 · shares: The option vests pro rata on a monthly basis over 36 months. F1 · derivative.exercise_date: The option vests pro rata on a monthly basis over 36 months. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 22:56 UTC |
Schuyler KevinDirector
|
GrantStock Option · Derivative | 40,000 | $0.00 Strike: $3.11 | $0.00 |
DisclosureSEC source: 0001213900-21-008168 · ownership.xml · derivative · entry 1 Schuyler Kevin · CIK 0001718094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2031-02-07 F1 · shares: The option vests pro rata on a monthly basis over 36 months. F1 · derivative.exercise_date: The option vests pro rata on a monthly basis over 36 months. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 22:54 UTC |
Newman James W. Jr.Director
|
GrantStock Option · Derivative | 40,000 | $0.00 Strike: $3.11 | $0.00 |
DisclosureSEC source: 0001213900-21-008165 · ownership.xml · derivative · entry 1 Newman James W. Jr. · CIK 0001718364 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2031-02-07 F1 · shares: The option vests pro rata on a monthly basis over 36 months. F1 · derivative.exercise_date: The option vests pro rata on a monthly basis over 36 months. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 22:48 UTC |
Gilliland Robertson H.Director
|
GrantStock Option · Derivative | 40,000 | $0.00 Strike: $3.11 | $0.00 |
DisclosureSEC source: 0001213900-21-008158 · ownership.xml · derivative · entry 1 Gilliland Robertson H. · CIK 0001718351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2031-02-07 F1 · shares: The option vests pro rata on a monthly basis over 36 months. F1 · derivative.exercise_date: The option vests pro rata on a monthly basis over 36 months. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 22:46 UTC |
Anderson J. KermitDirector
|
GrantStock Option · Derivative | 40,000 | $0.00 Strike: $3.11 | $0.00 |
DisclosureSEC source: 0001213900-21-008154 · ownership.xml · derivative · entry 1 Anderson J. Kermit · CIK 0001717983 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2031-02-07 F1 · shares: The option vests pro rata on a monthly basis over 36 months. F1 · derivative.exercise_date: The option vests pro rata on a monthly basis over 36 months. Read SEC document |
| January 26, 2021 Filed Jan 28, 2021 19:45 UTC |
Stilley William B. IIIDirector · Chief Executive Officer · 10% owner
|
GrantCommon Stock | 201,109 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-21-005043 · ownership.xml · nonDerivative · entry 1 Stilley William B. III · CIK 0001718069 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 917,046 F1 · price: The reporting person acquired 201,109 shares of issuer common stock in exchange for an 28.7% interest in Purnovate, LLC ("Purnovate") pursuant to Purnovate's merger into a wholly owned subsidiary of the issuer, as contemplated by that certain Equity Purchase Agreement, dated December 7, 2020, as amended. The shares issued to the reporting person in the merger are currently being held in escrow and are subject to forfeiture during the two-year period following the merger to satisfy claims arising as a result of Purnovate's breach of any of its representations and warranties or covenants in the purchase agreement. Read SEC document |
| January 26, 2021 Filed Jan 29, 2021 00:44 UTC |
Newman James W. Jr.Director
|
GrantCommon Stock | 2,544 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-21-005041 · ownership.xml · nonDerivative · entry 4 Newman James W. Jr. · CIK 0001718364 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Virga Ventures, LLC Disclosed balance after: 152,963 F1 · price: The reporting person acquired an aggregate of 3,731 shares of issuer common stock in exchange for an aggregate 0.53% interest in Purnovate, LLC ("Purnovate") pursuant to Purnovate's merger into a wholly owned subsidiary of the issuer, as contemplated by that certain Equity Purchase Agreement, dated December 7, 2020, as amended. The shares issued to the reporting person in the merger are currently being held in escrow and 70% of the shares are subject to forfeiture during a one year period following the merger to satisfy claims arising as a result of Purnovate's breach of any of its representations and warranties or covenants in the purchase agreement. F4 · ownership.nature: James W. Newman is the sole member of Virga Ventures, LLC. Read SEC document |
| January 26, 2021 Filed Jan 29, 2021 00:44 UTC |
Newman James W. Jr.Director
|
GrantCommon Stock | 1,187 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-21-005041 · ownership.xml · nonDerivative · entry 2 Newman James W. Jr. · CIK 0001718364 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Roundtop Limited Partnership, LLP Disclosed balance after: 14,475 F1 · shares: The reporting person acquired an aggregate of 3,731 shares of issuer common stock in exchange for an aggregate 0.53% interest in Purnovate, LLC ("Purnovate") pursuant to Purnovate's merger into a wholly owned subsidiary of the issuer, as contemplated by that certain Equity Purchase Agreement, dated December 7, 2020, as amended. The shares issued to the reporting person in the merger are currently being held in escrow and 70% of the shares are subject to forfeiture during a one year period following the merger to satisfy claims arising as a result of Purnovate's breach of any of its representations and warranties or covenants in the purchase agreement. F1 · price: The reporting person acquired an aggregate of 3,731 shares of issuer common stock in exchange for an aggregate 0.53% interest in Purnovate, LLC ("Purnovate") pursuant to Purnovate's merger into a wholly owned subsidiary of the issuer, as contemplated by that certain Equity Purchase Agreement, dated December 7, 2020, as amended. The shares issued to the reporting person in the merger are currently being held in escrow and 70% of the shares are subject to forfeiture during a one year period following the merger to satisfy claims arising as a result of Purnovate's breach of any of its representations and warranties or covenants in the purchase agreement. F2 · ownership.nature: James W. Newman is the general partner of Roundtop Limited Partnership, LLP. Read SEC document |
| November 23, 2020 Filed Nov 25, 2020 21:48 UTC |
Schuyler KevinDirector
|
GiftWarrant to purchase common stock · Derivative | 89,600 | Not disclosed Strike: $5.00 | Not disclosed |
DisclosureSEC source: 0001213900-20-039336 · ownership.xml · derivative · entry 12 Schuyler Kevin · CIK 0001718094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 89,600 shares Expires 2023-07-31 F1 · price: Represents a transfer of warrants from Mr. Kevin Schuyler to The Kevin William Schuyler 2020 Irrevocable Perpetuities Trust, the trustee of which is Mr. Schuyler's wife and the beneficiaries of which are Mr. Schuyler's wife and children. F1 · derivative.underlying: Represents a transfer of warrants from Mr. Kevin Schuyler to The Kevin William Schuyler 2020 Irrevocable Perpetuities Trust, the trustee of which is Mr. Schuyler's wife and the beneficiaries of which are Mr. Schuyler's wife and children. Read SEC document |
| November 23, 2020 Filed Nov 25, 2020 21:48 UTC |
Schuyler KevinDirector
|
GiftWarrant to purchase common stock · Derivative | 82,461 | Not disclosed Strike: $6.25 | Not disclosed |
DisclosureSEC source: 0001213900-20-039336 · ownership.xml · derivative · entry 11 Schuyler Kevin · CIK 0001718094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 82,461 shares Expires 2023-07-31 F1 · price: Represents a transfer of warrants from Mr. Kevin Schuyler to The Kevin William Schuyler 2020 Irrevocable Perpetuities Trust, the trustee of which is Mr. Schuyler's wife and the beneficiaries of which are Mr. Schuyler's wife and children. F1 · derivative.underlying: Represents a transfer of warrants from Mr. Kevin Schuyler to The Kevin William Schuyler 2020 Irrevocable Perpetuities Trust, the trustee of which is Mr. Schuyler's wife and the beneficiaries of which are Mr. Schuyler's wife and children. Read SEC document |
| November 23, 2020 Filed Nov 25, 2020 21:48 UTC |
Schuyler KevinDirector
|
GiftWarrant to purchase common stock · Derivative | 89,600 | Not disclosed Strike: $6.25 | Not disclosed |
DisclosureSEC source: 0001213900-20-039336 · ownership.xml · derivative · entry 10 Schuyler Kevin · CIK 0001718094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 89,900 shares Expires 2023-07-31 F1 · price: Represents a transfer of warrants from Mr. Kevin Schuyler to The Kevin William Schuyler 2020 Irrevocable Perpetuities Trust, the trustee of which is Mr. Schuyler's wife and the beneficiaries of which are Mr. Schuyler's wife and children. F1 · derivative.underlying: Represents a transfer of warrants from Mr. Kevin Schuyler to The Kevin William Schuyler 2020 Irrevocable Perpetuities Trust, the trustee of which is Mr. Schuyler's wife and the beneficiaries of which are Mr. Schuyler's wife and children. Read SEC document |
| November 23, 2020 Filed Nov 25, 2020 21:48 UTC |
Schuyler KevinDirector
|
GiftWarrant to purchase common stock · Derivative | 89,600 | Not disclosed Strike: $6.25 | Not disclosed |
DisclosureSEC source: 0001213900-20-039336 · ownership.xml · derivative · entry 9 Schuyler Kevin · CIK 0001718094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 89,600 shares Expires 2023-07-31 F1 · price: Represents a transfer of warrants from Mr. Kevin Schuyler to The Kevin William Schuyler 2020 Irrevocable Perpetuities Trust, the trustee of which is Mr. Schuyler's wife and the beneficiaries of which are Mr. Schuyler's wife and children. F1 · derivative.underlying: Represents a transfer of warrants from Mr. Kevin Schuyler to The Kevin William Schuyler 2020 Irrevocable Perpetuities Trust, the trustee of which is Mr. Schuyler's wife and the beneficiaries of which are Mr. Schuyler's wife and children. Read SEC document |
| November 23, 2020 Filed Nov 25, 2020 21:48 UTC |
Schuyler KevinDirector
|
GiftWarrants to purchase common stock · Derivative | 8,649 | Not disclosed Strike: $7.63 | Not disclosed |
DisclosureSEC source: 0001213900-20-039336 · ownership.xml · derivative · entry 8 Schuyler Kevin · CIK 0001718094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,649 shares Expires 2023-07-31 F1 · price: Represents a transfer of warrants from Mr. Kevin Schuyler to The Kevin William Schuyler 2020 Irrevocable Perpetuities Trust, the trustee of which is Mr. Schuyler's wife and the beneficiaries of which are Mr. Schuyler's wife and children. F1 · derivative.underlying: Represents a transfer of warrants from Mr. Kevin Schuyler to The Kevin William Schuyler 2020 Irrevocable Perpetuities Trust, the trustee of which is Mr. Schuyler's wife and the beneficiaries of which are Mr. Schuyler's wife and children. Read SEC document |
| November 23, 2020 Filed Nov 25, 2020 21:48 UTC |
Schuyler KevinDirector
|
GiftWarrant to purchase common stock · Derivative | 1,010 | Not disclosed Strike: $0.01 | Not disclosed |
DisclosureSEC source: 0001213900-20-039336 · ownership.xml · derivative · entry 7 Schuyler Kevin · CIK 0001718094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,010 shares Expires 2023-07-31 F1 · price: Represents a transfer of warrants from Mr. Kevin Schuyler to The Kevin William Schuyler 2020 Irrevocable Perpetuities Trust, the trustee of which is Mr. Schuyler's wife and the beneficiaries of which are Mr. Schuyler's wife and children. F1 · derivative.underlying: Represents a transfer of warrants from Mr. Kevin Schuyler to The Kevin William Schuyler 2020 Irrevocable Perpetuities Trust, the trustee of which is Mr. Schuyler's wife and the beneficiaries of which are Mr. Schuyler's wife and children. Read SEC document |
| November 23, 2020 Filed Nov 25, 2020 21:48 UTC |
Schuyler KevinDirector
|
GiftWarrant to purchase common stock · Derivative | 89,600 | Not disclosed Strike: $5.00 | Not disclosed |
DisclosureSEC source: 0001213900-20-039336 · ownership.xml · derivative · entry 6 Schuyler Kevin · CIK 0001718094 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 89,600 Underlying: Common Stock · 89,600 shares Expires 2023-07-31 F1 · price: Represents a transfer of warrants from Mr. Kevin Schuyler to The Kevin William Schuyler 2020 Irrevocable Perpetuities Trust, the trustee of which is Mr. Schuyler's wife and the beneficiaries of which are Mr. Schuyler's wife and children. F1 · derivative.underlying: Represents a transfer of warrants from Mr. Kevin Schuyler to The Kevin William Schuyler 2020 Irrevocable Perpetuities Trust, the trustee of which is Mr. Schuyler's wife and the beneficiaries of which are Mr. Schuyler's wife and children. F1 · ownership.nature: Represents a transfer of warrants from Mr. Kevin Schuyler to The Kevin William Schuyler 2020 Irrevocable Perpetuities Trust, the trustee of which is Mr. Schuyler's wife and the beneficiaries of which are Mr. Schuyler's wife and children. Read SEC document |
| November 23, 2020 Filed Nov 25, 2020 21:48 UTC |
Schuyler KevinDirector
|
GiftWarrants to purchase common stock · Derivative | 82,461 | Not disclosed Strike: $6.25 | Not disclosed |
DisclosureSEC source: 0001213900-20-039336 · ownership.xml · derivative · entry 5 Schuyler Kevin · CIK 0001718094 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 82,461 Underlying: Common Stock · 82,461 shares Expires 2023-07-31 F1 · price: Represents a transfer of warrants from Mr. Kevin Schuyler to The Kevin William Schuyler 2020 Irrevocable Perpetuities Trust, the trustee of which is Mr. Schuyler's wife and the beneficiaries of which are Mr. Schuyler's wife and children. F1 · derivative.underlying: Represents a transfer of warrants from Mr. Kevin Schuyler to The Kevin William Schuyler 2020 Irrevocable Perpetuities Trust, the trustee of which is Mr. Schuyler's wife and the beneficiaries of which are Mr. Schuyler's wife and children. F1 · ownership.nature: Represents a transfer of warrants from Mr. Kevin Schuyler to The Kevin William Schuyler 2020 Irrevocable Perpetuities Trust, the trustee of which is Mr. Schuyler's wife and the beneficiaries of which are Mr. Schuyler's wife and children. Read SEC document |
| November 23, 2020 Filed Nov 25, 2020 21:48 UTC |
Schuyler KevinDirector
|
GiftWarrants to purchase common stock · Derivative | 89,600 | Not disclosed Strike: $6.25 | Not disclosed |
DisclosureSEC source: 0001213900-20-039336 · ownership.xml · derivative · entry 4 Schuyler Kevin · CIK 0001718094 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 89,600 Underlying: Common Stock · 89,600 shares Expires 2023-07-31 F1 · price: Represents a transfer of warrants from Mr. Kevin Schuyler to The Kevin William Schuyler 2020 Irrevocable Perpetuities Trust, the trustee of which is Mr. Schuyler's wife and the beneficiaries of which are Mr. Schuyler's wife and children. F1 · derivative.underlying: Represents a transfer of warrants from Mr. Kevin Schuyler to The Kevin William Schuyler 2020 Irrevocable Perpetuities Trust, the trustee of which is Mr. Schuyler's wife and the beneficiaries of which are Mr. Schuyler's wife and children. F1 · ownership.nature: Represents a transfer of warrants from Mr. Kevin Schuyler to The Kevin William Schuyler 2020 Irrevocable Perpetuities Trust, the trustee of which is Mr. Schuyler's wife and the beneficiaries of which are Mr. Schuyler's wife and children. Read SEC document |
| November 23, 2020 Filed Nov 25, 2020 21:48 UTC |
Schuyler KevinDirector
|
GiftWarrants to purchase common stock · Derivative | 89,600 | Not disclosed Strike: $6.25 | Not disclosed |
DisclosureSEC source: 0001213900-20-039336 · ownership.xml · derivative · entry 3 Schuyler Kevin · CIK 0001718094 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 89,600 Underlying: Common Stock · 89,600 shares Expires 2023-07-31 F1 · price: Represents a transfer of warrants from Mr. Kevin Schuyler to The Kevin William Schuyler 2020 Irrevocable Perpetuities Trust, the trustee of which is Mr. Schuyler's wife and the beneficiaries of which are Mr. Schuyler's wife and children. F1 · derivative.underlying: Represents a transfer of warrants from Mr. Kevin Schuyler to The Kevin William Schuyler 2020 Irrevocable Perpetuities Trust, the trustee of which is Mr. Schuyler's wife and the beneficiaries of which are Mr. Schuyler's wife and children. F1 · ownership.nature: Represents a transfer of warrants from Mr. Kevin Schuyler to The Kevin William Schuyler 2020 Irrevocable Perpetuities Trust, the trustee of which is Mr. Schuyler's wife and the beneficiaries of which are Mr. Schuyler's wife and children. Read SEC document |
| November 23, 2020 Filed Nov 25, 2020 21:48 UTC |
Schuyler KevinDirector
|
GiftWarrants to purchase common stock · Derivative | 8,649 | Not disclosed Strike: $7.63 | Not disclosed |
DisclosureSEC source: 0001213900-20-039336 · ownership.xml · derivative · entry 2 Schuyler Kevin · CIK 0001718094 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 8,649 Underlying: Common Stock · 8,649 shares Expires 2023-07-31 F1 · price: Represents a transfer of warrants from Mr. Kevin Schuyler to The Kevin William Schuyler 2020 Irrevocable Perpetuities Trust, the trustee of which is Mr. Schuyler's wife and the beneficiaries of which are Mr. Schuyler's wife and children. F1 · derivative.underlying: Represents a transfer of warrants from Mr. Kevin Schuyler to The Kevin William Schuyler 2020 Irrevocable Perpetuities Trust, the trustee of which is Mr. Schuyler's wife and the beneficiaries of which are Mr. Schuyler's wife and children. F1 · ownership.nature: Represents a transfer of warrants from Mr. Kevin Schuyler to The Kevin William Schuyler 2020 Irrevocable Perpetuities Trust, the trustee of which is Mr. Schuyler's wife and the beneficiaries of which are Mr. Schuyler's wife and children. Read SEC document |
| November 23, 2020 Filed Nov 25, 2020 21:48 UTC |
Schuyler KevinDirector
|
GiftWarrant to purchase common stock · Derivative | 1,010 | Not disclosed Strike: $0.01 | Not disclosed |
DisclosureSEC source: 0001213900-20-039336 · ownership.xml · derivative · entry 1 Schuyler Kevin · CIK 0001718094 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,010 Underlying: Common Stock · 1,010 shares Expires 2023-07-31 F1 · price: Represents a transfer of warrants from Mr. Kevin Schuyler to The Kevin William Schuyler 2020 Irrevocable Perpetuities Trust, the trustee of which is Mr. Schuyler's wife and the beneficiaries of which are Mr. Schuyler's wife and children. F1 · derivative.underlying: Represents a transfer of warrants from Mr. Kevin Schuyler to The Kevin William Schuyler 2020 Irrevocable Perpetuities Trust, the trustee of which is Mr. Schuyler's wife and the beneficiaries of which are Mr. Schuyler's wife and children. F1 · ownership.nature: Represents a transfer of warrants from Mr. Kevin Schuyler to The Kevin William Schuyler 2020 Irrevocable Perpetuities Trust, the trustee of which is Mr. Schuyler's wife and the beneficiaries of which are Mr. Schuyler's wife and children. Read SEC document |
| August 20, 2020 Filed Aug 24, 2020 16:59 UTC |
Johnson Bankole A.Chief Medical Officer
|
SaleCommon Stock | 350,000 | $1.21 | $423,500.00 |
DisclosureSEC source: 0001213900-20-023494 · ownership.xml · nonDerivative · entry 1 Johnson Bankole A. · CIK 0001718158 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,055 F1 · kind: The reporting person sold 350,000 shares of the issuer's common stock pursuant to a Stock Purchase Agreement dated as of August 19, 2020 for an aggregate purchase price of $425,000. Read SEC document |
| May 19, 2020 Filed May 20, 2020 19:14 UTC |
REICH JACK WDirector
|
GrantStock Option · Derivative | 90,000 | $0.00 Strike: $1.47 | $0.00 |
DisclosureSEC source: 0001213900-20-013163 · ownership.xml · derivative · entry 1 REICH JACK W · CIK 0001078450 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock · 90,000 shares Expires 2030-05-19 F1 · shares: The option vests pro rata on a monthly basis over 36 months. F1 · derivative.exercise_date: The option vests pro rata on a monthly basis over 36 months. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.